![David Cade](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Cade
Technik-/Wissenschafts-/F&E-Leiter bei
TELIX PHARMACEUTICALS LIMITED
Vermögen: 4 Mio $ am 31.07.2026
Profil
David N.
Cade is currently a Member at the Australian Institute of Co. Directors and Group Chief Medical Officer at Telix Pharmaceuticals Ltd. since 2024.
Formerly, Dr. Cade was Chief Medical Officer at Cochlear Ltd. and Chief Medical Officer at Sirtex Medical Pty Ltd. from 2012 to 2017.
Education includes an MBA from Melbourne Business School, a doctorate from Monash University, and an MBA from Escuela Superior de Administración y Dirección de Empresas.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 373 133 ( 0,11 % ) | 4 Mio $ | 31.07.2026 |
Aktive Positionen von David Cade
| Unternehmen | Position | Beginn |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von David Cade
| Unternehmen | Position | Ende |
|---|---|---|
| SIRTEX MEDICAL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2017 |
| COCHLEAR LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David Cade
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cochlear Ltd.
 Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
Sirtex Medical Pty Ltd.
 Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escuela Superior de Administración y Dirección de Empresas
 Escuela Superior de Administración y Dirección de Empresas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
